EGFR and non-small cell lung carcinoma: Additionally, mechanistic validation studies may also be performed on EGFR mutant and non-EGFR mutant cell lines to elucidate the biological roles of these candidate malignancy lipids, as this will provide interesting mechanistic insights to substantiate their relevance in NSCLC.